Looking to partner with companies developing small molecule and protein degradation therapeutics across a range of undrugged or hard-to-drug targets?
We partner with cutting-edge solution and service providers with small molecule specific capabilities in structural biology, medicinal chemistry, pre-clinical and clinical development, with the goal to assist the industry to overcome existing challenges to further progress in this emerging field to address unmet patient needs.
If you have relevant capabilities in this space and would like to align your brand with the small molecules and protein degradation community, contact us to promote your capabilities through a bespoke commercial package.
